← Human Trials & Peer-Reviewed Studies

Non-surgical periodontal therapy with adjunct photodynamic therapy for the management of periodontal inflammation in adults using nicotine-free electronic-cigarette: A randomized control trial.

Plain-language guide to PMID 35331959 (2022): pilot randomized controlled trial of Therapeutic nicotine (patch, non-peptide).

Key Facts

PMID
35331959
Journal
Photodiagnosis and photodynamic therapy
Year
2022
Study type
Randomized Controlled Trial
Authors
Alshibani N et al. (7 authors)
DOI
10.1016/j.pdpdt.2022.102820

What This Study Did, in Plain Language

What Was Tested

This randomized controlled trial looks at Therapeutic nicotine (patch, non-peptide).

The aim was to assess the effect of non-surgical periodontal therapy (NSPT) with adjunct photodynamic treatment (PDT) for the management of periodontal inflammation in young electronic cigarette (E-cig) users.

Who Took Part

PubMed indexes the participants as adults.

Patients with periodontal inflammation were included.

Patient demographics and information related to E-Cig usage were recorded.

How the Study Was Run

The researchers set it up as a randomized and pilot study.

Because people in this Therapeutic nicotine (patch, non-peptide) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

It is described as a pilot, a small early test of whether a larger Therapeutic nicotine (patch, non-peptide) study would be practical.

Scores of plaque index (PI), bleeding index (BI), clinical attachment loss (AL) and probing depth (PD) recorded at baseline and at 3-months' follow-up.

Patients were randomly divided into test (NSPT + PDT) and control groups (NSPT) alone.

Sample-size estimation was done using data from a pilot investigation and group comparisons were done.

Correlation between periodontal parameters and duration of E-cig use was assessed using regression analysis models.

Group-comparisons were done using the Mann Whitney U test; and logistic regression was done to correlate periodontal parameters with age, gender, frequency of vaping, number of puffs inhaled and oral hygiene maintenance protocols.

What Was Measured

The subject headings attached to it are Electronic Nicotine Delivery Systems, Electronics, Inflammation, Nicotine, Photochemotherapy and Tobacco Products.

The authors tagged it with the keywords Clinical attachment loss, Electronic cigarette, Non-surgical periodontal therapy and Photodynamic therapy.

What This Means in Plain Language

The paper is a randomized and pilot study of Therapeutic nicotine (patch, non-peptide).

Results are reported in around 6 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2022 (Photodiagnosis and photodynamic therapy), a journal based in Netherlands.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.

Our Notes on the Compound

Therapeutic nicotine (patch, non-peptide): Pure nicotine as a signaling tool, separated from smoking and vaping.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.